Simulations Plus, Inc. Logo

Simulations Plus, Inc.

Modeling & simulation software and consulting for pharma/biotech to accelerate drug development.

SLP | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
800 PARK OFFICES DRIVE, SUITE 401, 27709 RESEARCH TRIANGLE PARK
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and other science-based industries. The company specializes in solutions that support drug discovery and development, from early research and clinical development to regulatory submissions. Its flagship products, including GastroPlus® and ADMET Predictor®, utilize advanced technologies like AI/machine learning, physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP), and quantitative systems toxicology (QST) modeling. These tools enable scientists to predict the properties and effects of chemical and biological compounds, helping to optimize drug design, predict safety and efficacy, and accelerate the development timeline. The company serves a global client base, including major pharmaceutical companies, regulatory agencies, and academic institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Simulations Plus, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Simulations Plus, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Simulations Plus, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.